GURUFOCUS.COM » STOCK LIST » Healthcare » Drug Manufacturers » Ascendis Health Ltd (JSE:ASC) » Definitions » YoY EPS Growth

Ascendis Health (JSE:ASC) YoY EPS Growth : -175.85% (As of Jun. 2023)


View and export this data going back to 2013. Start your Free Trial

What is Ascendis Health YoY EPS Growth?

YoY EPS Growth is the percentage change of Earnings per Share (Diluted) over the past twelve months. Ascendis Health's YoY EPS Growth for the quarter that ended in Jun. 2023 was -175.85%.

Ascendis Health's Earnings per Share (Diluted) for the six months ended in Jun. 2023 was R-0.20.


Ascendis Health YoY EPS Growth Historical Data

The historical data trend for Ascendis Health's YoY EPS Growth can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

Ascendis Health YoY EPS Growth Chart

Ascendis Health Annual Data
Trend Jun14 Jun15 Jun16 Jun17 Jun18 Jun19 Jun20 Jun21 Jun22 Jun23
YoY EPS Growth
Get a 7-Day Free Trial Premium Member Only Premium Member Only -1,871.64 79.50 -11.96 141.84 -86.75

Ascendis Health Semi-Annual Data
Dec13 Jun14 Dec14 Jun15 Dec15 Jun16 Dec16 Jun17 Dec17 Jun18 Dec18 Jun19 Dec19 Jun20 Dec20 Jun21 Dec21 Jun22 Dec22 Jun23
YoY EPS Growth Get a 7-Day Free Trial Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only 64.98 148.52 130.85 -51.56 -175.85

Ascendis Health YoY EPS Growth Calculation

YoY EPS Growth is the percentage change of Earnings per Share (Diluted) over the past twelve months.

Ascendis Health's YoY EPS Growth for the fiscal year that ended in Jun. 2023 is calculated as:

YoY EPS Growth (A: Jun. 2023 )
=(Earnings per Share (Diluted) (A: Jun. 2023 )-Earnings per Share (Diluted) (A: Jun. 2022 ))/ | Earnings per Share (Diluted) (A: Jun. 2022 ) |
=(0.124-0.936)/ | 0.936 |
=-86.75 %

Ascendis Health's YoY EPS Growth for the quarter that ended in Jun. 2023 is calculated as:

YoY EPS Growth (Q: Jun. 2023 )
=(Earnings per Share (Diluted) (Q: Jun. 2023 )-Earnings per Share (Diluted) (Q: Jun. 2022 )) / | Earnings per Share (Diluted) (Q: Jun. 2022 )) |
=(-0.201-0.265)/ | 0.265 |
=-175.85 %

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.


Ascendis Health YoY EPS Growth Related Terms

Thank you for viewing the detailed overview of Ascendis Health's YoY EPS Growth provided by GuruFocus.com. Please click on the following links to see related term pages.


Ascendis Health (JSE:ASC) Business Description

Traded in Other Exchanges
N/A
Address
1 Carey Street, Wynberg, Sandton, GT, ZAF, 2090
Ascendis Health is a drug manufacturer that produces and distributes health products for the human, animal, and plant markets. It has a portfolio of brands and products and owns recognized trademarks in the pharmaceutical and consumer health markets. Ascendis Health has five operating segments: consumer health, pharma, medical, animal health, and biosciences. The pharma division is the contributor to revenue and is further divided into Pharma Africa, Remedica, and Farmalider. Pharma includes generic manufacturing and distribution and over-the-counter medicine manufacturing and distribution. The company's revenue is split between South Africa and Europe and is diversified across currencies, markets, sales channels, and customer groups.